Highlands Oncology

Rogers, Arkansas 72758

1 studies enrolling now · 6 studies all time

What they study most

Advanced or Metastatic Solid Tumors, Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors, Breast Cancer, Colorectal Cancer, Cutaneous Melanoma, MDM2 Gene Mutation, Malignant Peripheral Nerve Sheath Tumors (MPNST), Melanoma, Metastatic Castration-Resistant Prostate Cancer, Mucosal Melanoma, Non-Small Cell Lung Cancer, P53 Mutation

Studies at this site

• A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer. — Recruiting now
• Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease — Running, not enrolling
• A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer. — Running, not enrolling
• A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors — Running, not enrolling
• A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination — Stopped early
• Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors — Stopped early